Stock Titan Deals and strategy
Waldencast plc (WALD) repurchases 193,816 RSUs as Hind Sebti moves to Obagi
Waldencast plc reported the repurchase of 193,816 Restricted Stock Units (RSUs) from its Chief Growth Officer, Hind Sebti, at $2.00 per RSU. This transaction occurred in connection with the sale of Waldencast's Obagi Medical business, which Sebti is now leading. Following this disposition, Sebti holds no remaining RSUs from an original grant made in October 2024.